Avita Therapeutics Inc

NASDAQ:RCEL  
22.96
+0.87 (+3.94%)
Products, Strategic Combinations

Avita Therapeutics Announces Collaboration With Houston Methodist Research Institute To Explore Novel Approaches For Skin Rejuvenation

Published: 11/09/2020 13:31 GMT
Avita Therapeutics, Inc. (RCEL) - Avita Therapeutics and Houston Methodist Research Institute Enter Into Collaboration to Explore Novel Approaches for Skin Rejuvenation.
Avita Therapeutics Inc - Avita Therapeutics Secures Exclusive Licensing Option.
Avita - Preclinical Research Will Pair Co's Spray-on Skin Cells With Houston Methodist Research Institute's Technologies to Reverse Cellular Aging.
Avita Therapeutics Inc - Entered Option Agreement to Negotiate an Exclusive, Worldwide License to This Patented Technology for Skin Applications.